glp-1 gip therapies muscle preservation 2025 How Helps Support Lean GLP-1 receptor agonists and next-generation

a Japanese single-center, retrospective study

Struggling with weight loss isnt just about willpowerits about science

Approval of the drug would be a win for Lilly as it tries to maintain dominance over the GLP-1 market, where it has already overtaken rival company Novo Nordisk, manufacturer of Ozempic and Wegovy

This powerhouse ingredient fights free radicals and environmental stressors that can accelerate the visible signs of aging

A study published last summer by JAMA Oncology looked at GLP-1 use and 14 obesity-related cancers and found that while the weight-loss drug lowered the risk of most cancers, there was a nonsignificant increased risk of kidney cancer particularly among people younger than 65